TSS
AUPH icon

Two Sigma Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History

Two Sigma Securities’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,703
Closed -$173K – 1726
2026
Q1 		$173K Buy
+11,703
New +$171K 0.02% 1076
2025
Q4 		– Sell
-11,539
Closed -$128K – 1471
2025
Q3 		$128K Sell
11,539
-2,920
-20% -$31.9K 0.02% 878
2025
Q2 		$122K Sell
14,459
-16,285
-53% -$131K 0.02% 1018
2025
Q1 		$247K Buy
+30,744
New +$249K 0.04% 722
2024
Q1 		– Sell
-15,738
Closed -$141K – 2967
2023
Q4 		$141K Buy
15,738
+5,084
+48% +$41.9K ﹤0.01% 2473
2023
Q3 		$82.8K Sell
10,654
-13,313
-56% -$130K ﹤0.01% 2418
2023
Q2 		$232K Buy
+23,967
New +$249K ﹤0.01% 2086
2023
Q1 		– Sell
-20,026
Closed -$86.5K – 2643
2022
Q4 		$86.5K Buy
+20,026
New +$116K ﹤0.01% 2088
2017
Q2 		– Sell
-32,652
Closed -$240K – 859
2017
Q1 		$240K Buy
+32,652
New +$151K 0.05% 499

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Securities's AUPH Position: Q2 2026 in Review

Two Sigma Securities sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 11,703 shares — an estimated $173K sold.

Two Sigma Securities first reported a position in AUPH in Q1 2017 and held it in 9 quarters. The position peaked at $247K in Q1 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Two Sigma Securities reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 11,703 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $173K.
  • Two Sigma Securities first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 9 quarters.
  • Two Sigma Securities's Aurinia Pharmaceuticals position peaked at $247K in Q1 2025.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.